Want to see IN:CAMLINFINE full AI Analyst Report?
CAMLINFINE Stock Chart & Stats
₹129.15
-₹4.44(-3.41%)
At close: 4:00 PM EDT
₹129.15
-₹4.44(-3.41%)
Day’s Range― - ―
52-Week Range₹96.30 - ₹234.00
Previous CloseN/A
Volume328.64K
Average Volume (3M)39.05K
Market Cap
₹20.96B
Enterprise Value₹24.10K
Total Cash (Recent Filing)₹1.53B
Total Debt (Recent Filing)₹7.20B
Price to Earnings (P/E)421.0
Beta0.65
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.38
Shares Outstanding192,096,620
10 Day Avg. Volume26,894
30 Day Avg. Volume39,045
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.76
Price to Sales (P/S)1.06
P/FCF Ratio-55.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.55
Revenue Forecast (FY)₹22.03B
Bulls Say, Bears Say
Bulls Say
Diversified Specialty-ingredient PlatformExposure to multiple end markets and recurring B2B ingredient demand can reduce reliance on any single customer sector. Customized blends and application know-how may also support customer retention and differentiation over time.
Improved LeverageLower leverage provides greater financial flexibility than in FY2023 and can reduce balance-sheet pressure during operating volatility. The improvement supports continued investment in specialty-chemical capacity and market reach.
Return To ProfitabilityReturning to positive earnings shows that the business retains a path to profitability despite recent volatility. If sustained through better utilization and product mix, this could provide a foundation for rebuilding earnings quality.
Bears Say
Sharp Revenue ContractionThe steep FY2026 revenue decline indicates substantial demand, portfolio, or execution volatility. Persistent contraction would weaken operating scale, reduce customer momentum, and make recovery in margins and cash generation more difficult.
Compressed ProfitabilityMaterial margin erosion leaves limited buffer against raw-material inflation, pricing pressure, or lower capacity utilization. Thin current profitability also reduces the ability to fund growth internally and makes earnings more vulnerable.
Weak And Inconsistent Cash ConversionRepeated negative free cash flow suggests that working capital, reinvestment, or other funding needs are absorbing earnings. Weak conversion can constrain deleveraging and expansion, while increasing reliance on external financing.
Camlin Fine Sciences Limited News
CAMLINFINE FAQ
What was Camlin Fine Sciences Limited’s price range in the past 12 months?
Camlin Fine Sciences Limited lowest stock price was ₹96.30 and its highest was ₹234.00 in the past 12 months.
What is Camlin Fine Sciences Limited’s market cap?
Camlin Fine Sciences Limited’s market cap is ₹20.96B.
When is Camlin Fine Sciences Limited’s upcoming earnings report date?
Camlin Fine Sciences Limited’s upcoming earnings report date is Nov 05, 2026 which is in 74 days.
How were Camlin Fine Sciences Limited’s earnings last quarter?
Camlin Fine Sciences Limited released its earnings results on Aug 11, 2026. The company reported -₹0.6 earnings per share for the quarter, missing the consensus estimate of ₹0.12 by -₹0.72.
Is Camlin Fine Sciences Limited overvalued?
According to Wall Street analysts Camlin Fine Sciences Limited’s price is currently Overvalued.
Does Camlin Fine Sciences Limited pay dividends?
Camlin Fine Sciences Limited pays a Annually dividend of ₹0.45 which represents an annual dividend yield of N/A. See more information on Camlin Fine Sciences Limited dividends here
What is Camlin Fine Sciences Limited’s EPS estimate?
Camlin Fine Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Camlin Fine Sciences Limited have?
Camlin Fine Sciences Limited has 192,096,620 shares outstanding.
What happened to Camlin Fine Sciences Limited’s price movement after its last earnings report?
Camlin Fine Sciences Limited reported an EPS of -₹0.6 in its last earnings report, missing expectations of ₹0.12. Following the earnings report the stock price went up 0.684%.
Which hedge fund is a major shareholder of Camlin Fine Sciences Limited?
Currently, no hedge funds are holding shares in IN:CAMLINFINE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, an India-based company headquartered in Mumbai and established in 1931 (originally as Camlin Fine Chemicals Limited until August 2011), is involved in the global research, development, production, and distribution of a diverse range of specialty chemicals, ingredients, and additive formulations. The company offers extensive shelf-life extension solutions under its Xtendra and NaSure brands. These include various antioxidants such as Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, alongside natural alternatives like mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Additionally, its offerings comprise mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Its product line also features aroma ingredients, notably vanillin and ethyl vanillin, as well as nutraceuticals sourced through fermentation and plant extraction processes. Furthermore, Camlin Fine Sciences provides performance chemicals like hydroquinone and catechol, and a selection of downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, and HQEE. These versatile products cater to numerous industries worldwide, encompassing food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemicals, agrochemicals, pharmaceuticals, polymers, dyes and pigments, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplements. The company actively engages in international exports of its goods.
Technical Analysis
Fineotex Chemical Limited
―
GOCL Corporation Limited
―
Kiri Industries Limited
―
NOCIL Limited
―
Rossari Biotech Ltd
―








